Saved in:
| Main Authors: | Stephen Langley, Jeremy Goad, Stephanie Bell, Lee Foster, Catherine Hodges, Marc Laniado, Michele Pietrasik, Alison Rooke, Matthew Knight, Edward Bosonnet, Simon Bott |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.416 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
by: Esther H. J. Hamoen, et al.
Published: (2025)
by: Esther H. J. Hamoen, et al.
Published: (2025)
Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
by: Sofia Mesquita, et al.
Published: (2025)
by: Sofia Mesquita, et al.
Published: (2025)
Potential gains from radical treatment of men with prostate cancer according to life expectancy
by: Sandra Irenaeus, et al.
Published: (2025)
by: Sandra Irenaeus, et al.
Published: (2025)
MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
by: Herbert Lepor, et al.
Published: (2025)
by: Herbert Lepor, et al.
Published: (2025)
Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
by: Jeremy Cheng, et al.
Published: (2025)
by: Jeremy Cheng, et al.
Published: (2025)
A pilot study evaluating the safety and efficacy of En‐bloc holmium laser enucleation of the prostate in patients with a history of radiation therapy or high intensity focused ultrasound for management of organ confined prostate cancer with review of the literature
by: Renil S. Titus, et al.
Published: (2025)
by: Renil S. Titus, et al.
Published: (2025)
Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer
by: Mohammadmehdi Adhami, et al.
Published: (2026)
by: Mohammadmehdi Adhami, et al.
Published: (2026)
Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
by: Maxwell Louis Sandberg, et al.
Published: (2026)
by: Maxwell Louis Sandberg, et al.
Published: (2026)
Incorporating the NICE Cambridge Prognostic Groups and Predict Prostate into a structured informed‐decision making clinic reduces over‐treatment rates of early prostate cancer
by: Vincent J. Gnanapragasam, et al.
Published: (2025)
by: Vincent J. Gnanapragasam, et al.
Published: (2025)
Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
by: Samantha Shekar, et al.
Published: (2025)
by: Samantha Shekar, et al.
Published: (2025)
Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
by: Eric Margolis, et al.
Published: (2025)
by: Eric Margolis, et al.
Published: (2025)
Day‐case artificial urinary sphincter for post‐prostatectomy incontinence: A comparative pilot study
by: Konstantinos Kapriniotis, et al.
Published: (2024)
by: Konstantinos Kapriniotis, et al.
Published: (2024)
The carbon footprint of transperineal prostate biopsy
by: Daniel A. Carson, et al.
Published: (2025)
by: Daniel A. Carson, et al.
Published: (2025)
A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era
by: Jennifer Ward, et al.
Published: (2025)
by: Jennifer Ward, et al.
Published: (2025)
Emerging tools for the early detection of prostate cancer
by: Muhammad Haider, et al.
Published: (2025)
by: Muhammad Haider, et al.
Published: (2025)
Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
by: Sophia M. Abusamra, et al.
Published: (2025)
by: Sophia M. Abusamra, et al.
Published: (2025)
Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
by: Abel Tesfai, et al.
Published: (2024)
by: Abel Tesfai, et al.
Published: (2024)
Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
by: Ansh Bhatia, et al.
Published: (2024)
by: Ansh Bhatia, et al.
Published: (2024)
Bibliometric analysis of focal therapy in prostate cancer research
by: Mohammed Shahait, et al.
Published: (2024)
by: Mohammed Shahait, et al.
Published: (2024)
‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
by: Ryan Sutherland, et al.
Published: (2024)
by: Ryan Sutherland, et al.
Published: (2024)
Outcomes following intradetrusor onabotulinumtoxinA injections and sacral neuromodulation in older men
by: Leo D. Dreyfuss, et al.
Published: (2026)
by: Leo D. Dreyfuss, et al.
Published: (2026)
Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
by: Ailene E. Corona, et al.
Published: (2026)
by: Ailene E. Corona, et al.
Published: (2026)
The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
by: André B. Silva, et al.
Published: (2026)
by: André B. Silva, et al.
Published: (2026)
Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
by: Mathew Thakur, et al.
Published: (2024)
by: Mathew Thakur, et al.
Published: (2024)
Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
by: Eric V. Li, et al.
Published: (2024)
by: Eric V. Li, et al.
Published: (2024)
National survey of urologists' views on prostate cancer screening in the United Kingdom
by: Nikhil Mayor, et al.
Published: (2026)
by: Nikhil Mayor, et al.
Published: (2026)
Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
by: Nadia Rokan, et al.
Published: (2025)
by: Nadia Rokan, et al.
Published: (2025)
Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
by: Emilien Seizilles de Mazancourt, et al.
Published: (2025)
by: Emilien Seizilles de Mazancourt, et al.
Published: (2025)
Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
by: Ruth Pidsley, et al.
Published: (2024)
by: Ruth Pidsley, et al.
Published: (2024)
WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
by: Mohamad Baker Berjaoui, et al.
Published: (2024)
by: Mohamad Baker Berjaoui, et al.
Published: (2024)
Multivariable model integrating PHI and mpMRI for detecting csPCa in biopsy‐naïve men
by: Mario Dominguez Esteban, et al.
Published: (2025)
by: Mario Dominguez Esteban, et al.
Published: (2025)
Outcome of post‐prostatectomy stress urinary incontinence surgery in men with preoperative idiopathic detrusor overactivity
by: Nikita R. Bhatt, et al.
Published: (2024)
by: Nikita R. Bhatt, et al.
Published: (2024)
The significant costs of prostate cancer management—An analysis from a Caribbean hospital
by: Geneva Pantoja, et al.
Published: (2025)
by: Geneva Pantoja, et al.
Published: (2025)
Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
by: Lu Yu Kuo, et al.
Published: (2025)
by: Lu Yu Kuo, et al.
Published: (2025)
Risk factors of negative prostate biopsies: A CHAID decision tree analysis
by: Pierre Allainguillaume, et al.
Published: (2026)
by: Pierre Allainguillaume, et al.
Published: (2026)
Cytoreductive Radical Prostatectomy in Oligometastatic Prostate Cancer: Single‐Centre Experience
by: Khawaja Abdul Rouf, et al.
Published: (2026)
by: Khawaja Abdul Rouf, et al.
Published: (2026)
Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
by: Jonathon Dawson, et al.
Published: (2024)
by: Jonathon Dawson, et al.
Published: (2024)
A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
by: Marcus Sondermann, et al.
Published: (2025)
by: Marcus Sondermann, et al.
Published: (2025)
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024)
by: Arjun Pon Avudaiappan, et al.
Published: (2024)
Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
by: Muhammad Haider, et al.
Published: (2025)
by: Muhammad Haider, et al.
Published: (2025)
Similar Items
-
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
by: Esther H. J. Hamoen, et al.
Published: (2025) -
Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
by: Sofia Mesquita, et al.
Published: (2025) -
Potential gains from radical treatment of men with prostate cancer according to life expectancy
by: Sandra Irenaeus, et al.
Published: (2025) -
MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
by: Herbert Lepor, et al.
Published: (2025) -
Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
by: Jeremy Cheng, et al.
Published: (2025)